Author

S. Owen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

A. F. Buckley· 1 shared A. Grossblatt-Wait· 1 shared A. Guimaraes· 1 shared A. Kardosh· 1 shared A. L. Creason· 1 shared B. Brinkerhoff· 1 shared B. C. Sheppard· 1 shared B. J. Kang· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. F. Buckley

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ongoing Replication Stress Response and New Clonal T Cell Development Discriminate Between Liver and Lung Recurrence Sites and Patient Outcomes in Pancreatic Ductal Adenocarcinoma

J. M. Link, C. Pelz, P. J. Worth, S. Owen, D. Keith, E. M. Langer, A. Grossblatt-Wait, A. L. Creason, J. Egger, H. Holly, I. English, K. MacPherson, M. Tsuda, J. Goecks, E. Demir, , R. C. Sears

This study identifies transcriptomic and immune features distinguishing liver and lung metastatic sites in PDAC, linking replication stress response and T cell clonal development to patient outcomes.

bioRxiv · May 4, 2022 · PreprintCancer Biology

Cytostatic hypothermia and its impact on glioblastoma and survival

S. F. Enam, C. Y. Kilic, J. Huang, B. J. Kang, R. Chen, C. S. Tribble, E. Ilich, M. I. Betancur, S. J. Blocker, S. Owen, A. F. Buckley, J. G. Lyon, R. V. Bellamkonda

This paper investigates cytostatic hypothermia as a therapeutic approach for glioblastoma, showing it extends survival in rodent models by halting tumor growth without chemical interventions.

bioRxiv · Mar 25, 2021Bioengineering